JW Pharmaceutical001060
JW Pharmaceutical (001060) Equity Acquisition, Sep 29, 2026
Filing date ·
JW Pharmaceutical decided to acquire all 2,000,000 shares of its affiliate Solidus Investment for KRW 30.728 billion.
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.